Skip to content

Simultaneous Fluoroscopic and Endoscopic Examination of the Oropharyngeal Phase of Deglutition

Simultaneous Fluoroscopic and Endoscopic Examination of the Oropharyngeal Phase of Deglutition

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00584623
Enrollment
0
Registered
2008-01-02
Start date
2007-03-31
Completion date
2008-06-30
Last updated
2017-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysphagia

Keywords

dysphagia, videofluoroscopy, flexible endoscopic evaluation

Brief summary

To correlate findings between two commonly-used types of swallowing studies: videofluoroscopy and flexible endoscopic evaluation of swallowing (FEES).

Detailed description

The specific aim of this study is to correlate findings between two commonly-used types of swallowing studies: videofluoroscopy and flexible endoscopic evaluation of swallowing (FEES). Specifically, the timing of swallowing events will be correlated between teh two studies. In addition, the pharyngeal constriction ratio (a validated measure of pharyngeal strength on videofluoroscopy) will be compared with the pharyngeal squeeze maneuver (an assessment of pharyngeal strength on FEES), with the hypothesis that there will be a strong correlation between PCR and pharyngeal squeeze.

Interventions

None listed

Sponsors

University of California, Davis
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* complaints of dysphagia * scheduled to undergo videofluoroscopy * able to tolerate both videofluoroscopic evaluation of swallowing and FEES

Exclusion criteria

* age less than 18 * contraindications to videofluoroscopy (reaction to barium, possible pregnancy) * contraindications to FEES (bilateral obstructing nasal pathology or nasopharyngeal stenosis) * specific/vulnerable populations (children, mentally handicapped, pregnant women, fetuses, prisoners, cognitive impairment, life-threatening disease, social or economic disadvantage)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026